| FACT SHEET
(as of 30, September 2005)
| FIRST YEAR OF OPERATIONS |
1978 |
| LISTED ON BSE & NSE |
2004 |
| WORLD WIDE WEB ADDRESS |
http://www.biocon.com |
| CHAIRMAN & MD |
Dr. Kiran Mazumdar-Shaw |
| BUSINESS FOCUS |
Fully integrated biotechnology
enterprise focused on biopharmaceuticals, enzymes,
custom research, clinical research and clinical
trials |
TOTAL REVENUE
(For half-year ended September 30, 2005)
|
Rs. 377 crores |
NET PROFIT
(For half-year ended September 30, 2005
|
Rs. 82 crores |
| SUBSIDIARIES |
- Syngene International Private
Limited
Provides chemistry and molecular biology based
custom research services in early stage drug
discovery and development for multinational
Pharma/Biotech companies.
- Clinigene International
Private Limited
Conducts longitudinal research in diabetes and
offers a wide range of comprehensive services
in clinical research and clinical trials
- Biocon Biopharmaceuticals,
joint venture with CIMAB for manufacturing monoclonal
antibodies and Cancer Vaccines
|
| GLOBAL REACH |
Over 50 countries |
| NUMBER OF EMPLOYEES |
1600+ with over 800 scientists
|
| AWARDS & RECOGNITION |
- Among the Top 20 global biotech companies
- Among India’s Top 5 Life Sciences companies
- “Express Pharma Pulse Award” for
excellence in the pharmaceutical industry, 2003
- Syngene International is awarded the Certificate
of Excellence for Export Achievement by the
Government of India, for two consecutive years
2002-2003
- Biocon awarded for “Organisation with
Innovative HR Practices” by Indira Group
|
| LEADERSHIP POSITION |
- Biocon has leadership position in US and Europe
for Lovastatin and Simvastatin in APIs
- Biocon is the only US FDA approved producer
of Lovastatin, Pravastatin, Simvastatin in India
- Syngene, a Biocon subsidiary, is the country’s
first biotech custom research company in drug
discovery
- Biocon’s subsidiary, Clinigene, has
India’s first CAP (College of American
Pathologists) accredited clinical research laboratory,
setting a standard for laboratories in India
- Biocon’s proprietary bioreactor, the
PlafractorÔ, has a US patent
- Biocon is the first biotech company to receive
ISO 9001 certification in India
- Biocon is the country’s first biotech
company to export microbial enzymes to
USA and Europe
|
|
